Market revenue in 2023 | USD 220.1 million |
Market revenue in 2030 | USD 300.2 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.48% in 2023. Horizon Databook has segmented the Middle East & Africa diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA diabetic foot ulcer treatment market is expected to witness rapid growth due to increasing prevalence of diabetes, rapidly aging population, and growing demand for home-based treatment options. According to the International Diabetes Federation, the Middle East accounted for the second-highest deaths due to diabetes among patients below 60 years.
The prevalence of diabetes is increasing mainly due to unhealthy lifestyle and risk factors like obesity, genetics, lack of proper awareness, and high cost of care. A sudden spike in the diabetic population was reported in the Middle East region.
Studies suggest that Kuwait, Saudi Arabia, and Bahrain rank in the top 10 countries with the highest prevalence of diabetes in the world. Thus, extensive government policies and diabetic care plans are needed to reduce the prevalence in this region, thereby driving the adoption of effective diabetic foot ulcer treatment products.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa diabetic foot ulcer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account